Results 41 to 50 of about 22,851 (227)

Simplifying Thromboprophylaxis Could Improve Outcomes in Orthopaedic Surgery [PDF]

open access: yes, 2010
Venous thromboembolism is a serious complication after total hip or knee surgery, and there is a well-established clinical need for thromboprophylaxis.
Richard J. Friedman
core   +1 more source

Aspirin for Thromboprophylaxis after a Fracture

open access: yes, 2023
To the Editor: Aspirin for thromboprophylaxis to prevent venous thromboembolism after hip- or knee-replacement surgery has been included in clinical guidelines.
van Twist, Daan J L   +2 more
core   +1 more source

Thromboprophylaxis in critical care

open access: yesIntensive Care Medicine, 2022
Contains fulltext : 290892.pdf (Publisher’s version ) (Open Access)
Julie Helms   +2 more
openaire   +5 more sources

A Large Retrospective Study to Evaluate Utility of Zephyr Covered Stent in Transcatheter Closure of Sinus Venosus Defects

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter closure (TCC) of sinus venosus defects (SVD) using balloon‐expandable covered stents is an emerging alternative to surgery. ZephyrCS (Sahajanand Laser Technologies, Gandhinagar, India) is available in long lengths to suit SVD closure.
Pramod Sagar   +3 more
wiley   +1 more source

Comparison of machine learning methods for prediction of venous thromboembolism among hospitalized adults

open access: yesJournal of Hospital Medicine, EarlyView.
Abstract Background Hospital‐acquired venous thromboembolism (HA‐VTE) is a significant cause of morbidity and mortality among hospitalized adults. Accurate prediction of HA‐VTE is crucial for timely intervention and prevention. While logistic regression is widely used for the development of clinical prediction models, there is ongoing interest in the ...
Yeji Ko   +7 more
wiley   +1 more source

TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial

open access: yesBMC Pediatrics, 2017
Background Venous thromboembolism (VTE) is a common and severe complication during treatment of acute lymphoblastic leukemia (ALL). An important cause is the intensive use of asparaginase.
Irene L. M. Klaassen   +12 more
doaj   +1 more source

Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines

open access: yesSwiss Medical Weekly, 2020
AIMS OF THE STUDY Many centres have noticed a high number of venous thromboembolism (VTE) events among critically ill inpatients with COVID-19 pneumonia.
Pierre Fontana   +5 more
doaj   +1 more source

Thromboprophylaxis in people hospitalized with COVID‐19: Assessing intermediate or standard doses in a retrospective cohort study

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2022
Background and Objectives Current clinical guidelines recommend thromboprophylaxis for adults hospitalized with coronavirus disease 2019 (COVID‐19), yet it is unknown whether higher doses of thromboprophylaxis offer benefits beyond standard doses ...
Kathleen M. Andersen   +13 more
doaj   +1 more source

Development and External Validation of a Postoperative Risk Score for Venous Thromboembolism in Epithelial Ovarian Cancer

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, is a major complication in women with epithelial ovarian cancer (EOC). We aimed to develop and externally validate an early postoperative risk score to identify EOC patients at increased risk of VTE after debulking surgery.
Qiu‐Lin Cui   +6 more
wiley   +1 more source

Predictors of thromboprophylaxis in hospitalised medical patients. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE). [PDF]

open access: yes, 2015
Both, underuse and overuse of thromboprophylaxis in hospitalised medical patients is common. We aimed to explore clinical factors associated with the use of pharmacological or mechanical thromboprophylaxis in acutely ill medical patients at high (Geneva ...
Korte, W   +37 more
core   +1 more source

Home - About - Disclaimer - Privacy